Cian Healthcare Limited (BOM:542678)
India · Delayed Price · Currency is INR 13.39
+0.63 (4.94%)
At close: Sep 4, 2026
Cian Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -232.93 | -259.78 | 8.49 | 20.3 | -55.34 |
Depreciation & Amortization | 39.15 | 43.91 | 54.67 | 54.31 | 42.75 |
Other Operating Activities | 132.12 | 23.75 | 46.66 | 46.63 | 53.91 |
Change in Accounts Receivable | 47.48 | 30.92 | 57.48 | 4.91 | -78.22 |
Change in Inventory | 210.26 | 148.52 | -42.84 | 27.28 | -86.47 |
Change in Accounts Payable | -281.59 | 104.05 | 41.72 | -83.98 | 149.24 |
Change in Other Net Operating Assets | 70.78 | 116.15 | -48.53 | -21.03 | 59.9 |
Operating Cash Flow | -14.72 | 207.52 | 117.64 | 48.41 | 85.78 |
Operating Cash Flow Growth | - | 76.40% | 143.02% | -43.56% | 44.58% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -8.21 | -4.06 | -9.79 | -13.25 | -173.18 |
Sale of Property, Plant & Equipment | 89.09 | - | - | - | - |
Investment in Securities | 47.85 | - | -5.77 | 37.4 | 56.17 |
Other Investing Activities | 3.93 | 1.51 | 0.99 | 1.4 | 130.96 |
Investing Cash Flow | 132.66 | -2.54 | -14.57 | 25.55 | 13.96 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 199.35 | - | 65.14 | - |
Long-Term Debt Issued | 252.82 | - | - | - | 4.91 |
Total Debt Issued | 252.82 | 199.35 | - | 65.14 | 4.91 |
Short-Term Debt Repaid | -396.3 | - | -32.36 | - | -81.73 |
Long-Term Debt Repaid | - | -206.38 | -18.88 | -87.48 | - |
Total Debt Repaid | -396.3 | -206.38 | -51.24 | -87.48 | -81.73 |
Net Debt Issued (Repaid) | -143.49 | -7.04 | -51.24 | -22.34 | -76.82 |
Issuance of Common Stock | 0.04 | - | - | - | 27.8 |
Repurchase of Common Stock | -358.11 | - | - | - | - |
Other Financing Activities | 217.87 | -32.18 | -53.2 | -51.74 | -60.54 |
Financing Cash Flow | -283.69 | -39.22 | -104.43 | -74.08 | -109.57 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | 0 | - |
Net Cash Flow | -165.74 | 165.76 | -1.36 | -0.12 | -9.83 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -22.92 | 203.46 | 107.85 | 35.16 | -87.4 |
Free Cash Flow Growth | - | 88.65% | 206.76% | - | - |
Free Cash Flow Margin | -7.78% | 65.94% | 17.43% | 5.12% | -11.20% |
Free Cash Flow Per Share | -0.92 | 8.14 | 4.32 | 1.41 | -3.50 |
Levered Free Cash Flow | -174.04 | 414.45 | 110.68 | -7.27 | -134.56 |
Unlevered Free Cash Flow | -172.7 | 430.86 | 145.59 | 28.87 | -96.03 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | - | 25.06 | 53.2 | 51.74 | 60.54 |
Change in Working Capital | 46.94 | 399.63 | 7.83 | -72.83 | 44.46 |